New treatment strategy targets somatostatin to prevent blood sugar drops in type 1 diabetes

Inhibiting the hormone somatostatin may be a new treatment strategy to prevent dangerous blood glucose drops in type 1 diabetes.

Pioneers of mRNA win Nobel — plus our interview; Eli Lilly’s M&A, leadership shuffle; UniQure layoffs as gene therapy players adapt; and more

Welcome back to Endpoints Weekly, your review of the week’s top biopharma headlines. Want this in your inbox every Saturday morning? Current Endpoints readers can visit

October 8, 2023

Suki Launches SDK to Power Voice AI Experiences with Bond Vet

What You Should Know: – Suki, the leader in voice artificial intelligence (AI) technology for healthcare, today announced the launch of extended capabilities of Suki

June 4, 2024

Prospect Capital is PSEC stock a good investment #stocks #stockmarket #shorts

August 17, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.